> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Joint Advisory Committee to Review Pain Drug
- URL: https://www.fdaweb.com/joint-advisory-committee-to-review-pain-drug/
- Published: 2018-01-03T12:00:00.000Z
- Updated: 2026-09-14T23:10:26.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5140406

*Federal Register* notice: FDA has announced a joint Anesthetic and Analgesic Drug Products Advisory Committee and Drug Safety and Risk Management Advisory Committee meeting 2/14\. The committees will discuss a Charleston Laboratories NDA for Hydexor, a fixed-dose combination oral tablet containing hydrocodone, acetaminophen, and promethazine, for the short-term management of acute pain severe enough to require an opioid analgesic while preventing and reducing opioid-induced nausea and vomiting. Panel members will also be asked to discuss the abuse potential of this non-abuse-deterrent product and whether it should be approved. To view the notice, click [here](https://www.gpo.gov/fdsys/pkg/FR-2018-01-02/pdf/2017-28250.pdf?ref=fdaweb.com).